Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Endoscopic versus conservative management of iron-deficiency anemia in patients on blood thinners

Official title: A Pilot Study Evaluating the Benefit of Endoscopic Assessment for Iron Deficiency Anemia in Patients Receiving Antithrombotic Therapy

Run by Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec · NCT07089030 · Data updated 2026-11-12

This trial will test whether a conservative medical approach with limited testing works as well as repeated endoscopic exams for people on blood thinners who have recurrent iron-deficiency anemia from obscure gastrointestinal bleeding.

More Iron Deficiency Anemia trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment20 (estimated)
SponsorCentre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
Academic / other
Locations1 site (Trois-Rivières, Quebec)
StatusRecruiting
StartedJune 6, 2023
Main results expectedJune 6, 2026
Study endsJune 6, 2026
Registry record updatedJuly 28, 2025
Trial IDNCT07089030 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults on anticoagulant or antiplatelet therapy with laboratory-confirmed iron-deficiency anemia, prior negative upper/lower endoscopy and capsule endoscopy within six months, who can read French and provide informed consent are ideal candidates.

Probably not a fit

Patients with ongoing overt gastrointestinal bleeding, recent acute cardiac or neurological events, pregnancy, known GI or hematologic malignancy, contraindications to capsule endoscopy, or prior major small-bowel surgery are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, randomized pilot assigns about 20 adults on anticoagulant or antiplatelet therapy with obscure GI bleeding to either repeated endoscopic evaluations as needed or a conservative approach with a single evaluation and regular lab monitoring. Participants in both arms receive iron supplementation or transfusions as clinically required. The primary goal is to determine feasibility and safety to inform a larger randomized trial, and a secondary goal is to compare quality of life between the approaches. The study requires prior negative EGD, colonoscopy, and capsule endoscopy within six months and French language ability for consent and follow-up.

Why it matters

Potential benefit: If successful, this approach could reduce the number of repeated invasive endoscopies and their risks for patients on antithrombotic therapy while maintaining clinical outcomes.

How similar studies have gone: There is limited randomized evidence directly comparing conservative monitoring to repeated endoscopic evaluation in this specific population, so this pilot is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adult men and postmenopausal women with iron deficiency anemia, and premenopausal women with iron deficiency anemia and a negative gynecological evaluation;

   a. Laboratory-confirmed iron deficiency anemia (hemoglobin \< 120 g/L for women, \< 130 g/L for men, and ferritin \< 30 ng/L);
2. Patients receiving anticoagulant or antiplatelet therapy
3. Negative esophagogastroduodenoscopy (EGD), colonoscopy, and capsule endoscopy for gastrointestinal bleeding within six months prior to study enrollment
4. Willing and able to provide written informed consent
5. Able to read and understand French

Exclusion Criteria:

1. Ongoing overt gastrointestinal bleeding
2. Acute coronary syndrome, acute neurological event, sepsis, or respiratory failure within the past week
3. Pregnant women
4. Known gastrointestinal or hematological malignancy
5. Contraindications to capsule endoscopy
6. History of bariatric surgery, gastrectomy, or segmental resection of the small intestine
7. Inability to take oral iron
8. Other sources of blood loss (e.g., urinary, gynecological, hematoma, hemolysis)

Where it's running

  • Centre hospitalier affilié universitaire régional de Trois-Rivières
    Trois-Rivières, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.